INKT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Mink Therapeutics Inc (INKT) is not a strong buy at this moment for a beginner investor with a long-term strategy. The technical indicators are neutral to bearish, there are no significant trading trends, no recent news or catalysts, and the financial performance shows consistent losses despite some YoY improvement. Without any strong positive signals or catalysts, it is advisable to hold off on investing in this stock right now.
The MACD is below 0 and negatively contracting, indicating weak momentum. The RSI is neutral at 45.064, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 11.092, with support at 10.664 and resistance at 11.519.
NULL identified. No recent news or events to act as a positive catalyst.
Bearish technical indicators, lack of significant trading trends, and weak financial performance.
In Q3 2025, revenue remained at 0 with no growth. Net income improved YoY but remains negative at -2,887,709. EPS improved to -0.65, up 41.30% YoY. Gross margin stayed at 0, showing no profitability.
No analyst ratings or price target changes available.
